Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Is viral vector therapy finally gaining traction in chemotherapy-resistant pediatric tumors? Theriva’s APAO 2026 data shows viral–chemotherapy synergy in eye tumors. Find out what VCN-01 signals for pediatric oncology's biologics future. bySoujanya RaviFebruary 6, 2026